AstraZeneca Gets European Union Approval For Moventig Drug
December 09 2014 - 2:50AM
Dow Jones News
By Tapan Panchal
LONDON--AstraZeneca PLC (AZN.LN) said Tuesday that the European
Commission has granted it marketing authorization for the
constipation drug Moventig.
The pharmaceutical company said Moventig is a drug the treatment
of opioid-induced constipation in adult patients who don't respond
to laxatives.
The marketing authorization applies to all member states of the
European Union, Iceland, Norway and Lichtenstein.
Write to Tapan Panchal at tapan.panchal@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024
